TherapeuticsMD (TXMD) EPS (Basic) Growth (1y) (2011 - 2026)
TherapeuticsMD (TXMD) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | -71.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -250.00% |
| Mar 31, 2026 | -3,897.23% |
| Dec 31, 2025 | -100.01% |
| Sep 30, 2025 | 341.98% |
| Jun 30, 2025 | 114.95% |
| Mar 31, 2025 | -122.63% |
| Dec 31, 2024 | 18,888.50% |
| Sep 30, 2024 | 98.00% |
| Mar 31, 2024 | 104.91% |
| Dec 31, 2023 | -98.05% |
| Sep 30, 2023 | 88.26% |
| Mar 31, 2023 | 96.33% |
| Dec 31, 2022 | -48.58% |
| Sep 30, 2022 | 72.44% |
| Jun 30, 2022 | 368.53% |
| Mar 31, 2022 | 36.24% |
| Dec 31, 2021 | 182.53% |
| Sep 30, 2021 | 6.13% |
| Jun 30, 2021 | 43.39% |
| Mar 31, 2021 | 45.84% |